Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr561 Inhibitors

Olr561 inhibitors represent a specialized class of chemical compounds that target and modulate the activity of the olfactory receptor 561 (Olr561). Olfactory receptors, including Olr561, are a subset of G-protein-coupled receptors (GPCRs) that are primarily responsible for detecting volatile odorant molecules, thus playing a critical role in the sense of smell. These receptors are characterized by their seven-transmembrane domain structure and their ability to activate intracellular signaling pathways upon binding to specific ligands. Inhibitors of Olr561 function by binding to the receptor, either competitively or allosterically, thereby preventing the receptor from interacting with its natural odorant ligands. This inhibition can lead to a disruption in the normal signal transduction processes, effectively altering the sensory perception mediated by Olr561.

Research into Olr561 inhibitors often focuses on understanding the molecular interactions between these inhibitors and the receptor. Structural biology techniques, such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, are employed to elucidate the binding sites and conformational changes induced by the inhibitors. Computational methods, including molecular docking and dynamics simulations, further complement these studies by predicting the energetics and stability of inhibitor-receptor complexes. These investigations not only provide insights into the fundamental mechanisms of olfactory signal modulation but also contribute to the broader understanding of GPCR function. The study of Olr561 inhibitors also intersects with organic chemistry, as the design and synthesis of these molecules involve sophisticated methodologies to ensure specificity and potency. Overall, the exploration of Olr561 inhibitors is a multidisciplinary endeavor that combines elements of biochemistry, structural biology, and computational chemistry to advance the knowledge of olfactory receptor regulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Abiraterone

154229-19-3sc-460288
10 mg
$276.00
(0)

Inhibits CYP17, potentially affecting androgen synthesis and proteins in androgen signaling pathways.

BYL719

1217486-61-7sc-391001
sc-391001A
sc-391001B
sc-391001C
sc-391001D
sc-391001E
5 mg
10 mg
50 mg
100 mg
500 mg
1 g
$391.00
$597.00
$755.00
$1192.00
$5000.00
$9370.00
2
(0)

PI3K inhibitor, potentially altering proteins involved in the AKT/mTOR signaling pathway.

Belinostat

414864-00-9sc-269851
sc-269851A
10 mg
100 mg
$156.00
$572.00
(1)

Inhibits histone deacetylases, potentially affecting gene expression and chromatin remodeling proteins.

XL-184 free base

849217-68-1sc-364657
sc-364657A
5 mg
10 mg
$94.00
$208.00
1
(1)

Inhibits MET, VEGFR, and RET, potentially affecting proteins in multiple signaling pathways.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

Inhibits Bruton's tyrosine kinase, potentially affecting proteins in B-cell receptor signaling.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

Inhibits cyclin-dependent kinases 4 and 6, potentially affecting cell cycle-related proteins.

Rucaparib

283173-50-2sc-507419
5 mg
$150.00
(0)

PARP inhibitor, potentially affecting proteins involved in DNA repair pathways.

EPZ6438

1403254-99-8sc-507456
1 mg
$66.00
(0)

Inhibits EZH2, potentially affecting gene expression through histone methylation.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$118.00
$337.00
$520.00
$832.00
$1632.00
10
(0)

BCL-2 inhibitor, potentially influencing apoptosis-related proteins.